Screening of three-dimensional spheroids of ovarian cancer: identification of novel therapeutics targeting stemness and chemoresistance.
作者信息
Said Neveen
机构信息
Departments of Cancer Biology, Pathology, and Urology, Wake Forest University School of Medicine and Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC, USA.
出版信息
Ann Transl Med. 2018 Nov;6(Suppl 1):S26. doi: 10.21037/atm.2018.09.41.
Abstract
摘要
相似文献
1
Screening of three-dimensional spheroids of ovarian cancer: identification of novel therapeutics targeting stemness and chemoresistance.卵巢癌三维球体的筛选：鉴定靶向干性和化疗耐药性的新型治疗方法。
Ann Transl Med. 2018 Nov;6(Suppl 1):S26. doi: 10.21037/atm.2018.09.41.
2
Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.癌症干细胞富集和化疗耐药的工程 3D 模型。
Neoplasia. 2019 Aug;21(8):822-836. doi: 10.1016/j.neo.2019.06.005. Epub 2019 Jul 9.
3
miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.miR-133b 通过靶向甲基转移酶 DOT1L 抑制结直肠癌细胞干性和化疗耐药性。
Exp Cell Res. 2019 Dec 1;385(1):111597. doi: 10.1016/j.yexcr.2019.111597. Epub 2019 Sep 13.
4
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.ALDH1A1 相关的干性在高级别浆液性卵巢癌中是一个负预后指标，但可通过 EGFR/mTOR-PI3K/极光激酶抑制剂进行靶向治疗。
J Pathol. 2020 Feb;250(2):159-169. doi: 10.1002/path.5356. Epub 2019 Dec 3.
5
Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT.通过 TGFβ1 驱动的 EMT，干性和化疗耐药性被赋予 OC 细胞。
J Cell Biochem. 2018 Jul;119(7):5775-5787. doi: 10.1002/jcb.26753. Epub 2018 Mar 14.
6
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.基于个性化医学的方法，利用卵巢癌干细胞球体模型来研究化疗耐药和肿瘤复发的模式。
Clin Cancer Res. 2017 Nov 15;23(22):6934-6945. doi: 10.1158/1078-0432.CCR-17-0133. Epub 2017 Aug 16.
7
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress.剪切应力作用下上皮性卵巢癌细胞的干性与化疗耐药性
Sci Rep. 2016 Jun 1;6:26788. doi: 10.1038/srep26788.
8
A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.一种新型 c-Kit/磷酸化抑制素轴通过 Notch3-PBX1 和 β-连环蛋白-ABCG2 信号增强卵巢癌干细胞特性和化疗耐药性。
J Biomed Sci. 2020 Mar 13;27(1):42. doi: 10.1186/s12929-020-00638-x.
9
MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.微小RNA-129-5p通过靶向DLK1抑制非小细胞肺癌细胞的干性和化疗耐药性。
Biochem Biophys Res Commun. 2017 Aug 19;490(2):309-316. doi: 10.1016/j.bbrc.2017.06.041. Epub 2017 Jun 12.
10
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.利用悬滴阵列形成稳定的小细胞数量三维卵巢癌球体用于临床前药物敏感性测定。
Gynecol Oncol. 2015 Jul;138(1):181-9. doi: 10.1016/j.ygyno.2015.04.014. Epub 2015 Apr 22.
引用本文的文献
1
HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP.HOXB9 通过诱导 ERCC-1、MRP-2 和 XIAP 表达来赋予卵巢癌细胞化疗耐药性。
Int J Mol Sci. 2023 Jan 8;24(2):1249. doi: 10.3390/ijms24021249.
2
The antitumor effect of miR-448 in epithelial ovarian cancer.miR-448在上皮性卵巢癌中的抗肿瘤作用。
Transl Cancer Res. 2020 Aug;9(8):4922-4930. doi: 10.21037/tcr-20-2464.
3
Preparation of doxorubicin-loaded collagen-PAPBA nanoparticles and their anticancer efficacy in ovarian cancer.载阿霉素胶原-PAPBA纳米颗粒的制备及其对卵巢癌的抗癌疗效
Ann Transl Med. 2020 Jul;8(14):880. doi: 10.21037/atm-20-5028.
本文引用的文献
1
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.利福昔酮通过逆转耐药性和肿瘤干细胞样特性增强紫杉醇在卵巢癌中的疗效。
Cancer Res. 2018 Aug 1;78(15):4370-4385. doi: 10.1158/0008-5472.CAN-17-3993. Epub 2018 Jun 11.
2
Cancer statistics, 2018.癌症统计数据，2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.基于个性化医学的方法，利用卵巢癌干细胞球体模型来研究化疗耐药和肿瘤复发的模式。
Clin Cancer Res. 2017 Nov 15;23(22):6934-6945. doi: 10.1158/1078-0432.CCR-17-0133. Epub 2017 Aug 16.
4
Hallmarks of cancer stem cell metabolism.癌症干细胞代谢的特征。
Br J Cancer. 2016 Jun 14;114(12):1305-12. doi: 10.1038/bjc.2016.152. Epub 2016 May 24.
5
Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.阿托伐醌的新用途：靶向线粒体复合物III和氧化磷酸化以根除癌症干细胞。
Oncotarget. 2016 Jun 7;7(23):34084-99. doi: 10.18632/oncotarget.9122.
6
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.卵巢癌复发风险评分：一种预测晚期卵巢癌治疗后复发的预后算法。
Int J Gynecol Cancer. 2015 Mar;25(3):416-22. doi: 10.1097/IGC.0000000000000361.
7
Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.假定的卵巢癌干细胞中氧化磷酸化参与过程的多个障碍：对使用糖酵解抑制剂进行维持治疗的启示。
Oncotarget. 2014 Sep 30;5(18):8703-15. doi: 10.18632/oncotarget.2367.
8
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.上皮性卵巢癌患者的癌症干细胞优先进行氧化磷酸化，并抵抗葡萄糖剥夺。
Oncotarget. 2014 Jun 30;5(12):4305-19. doi: 10.18632/oncotarget.2010.
9
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.U-251再探讨：胶质母细胞瘤细胞长期培养的遗传漂变和表型后果
Cancer Med. 2014 Aug;3(4):812-24. doi: 10.1002/cam4.219. Epub 2014 May 8.
10
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.阿司匹林、非阿司匹林非甾体抗炎药和对乙酰氨基酚的使用与侵袭性上皮性卵巢癌风险：卵巢癌协会联盟的 pooled 分析。
J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.
Zotero 插件